Motus GI enrolls 1st patient into Reduce study — 4 insights

Motus GI enrolled the first patient into its reliable endoscopic diagnosis utilizing cleansing enhancement or REDUCE study that'll test the ability of the Pure-Vu System to properly prepare bowels for a diagnostic colonoscopy procedure.

Here's what you should know.

1. Motus is conducting a single-arm, multicenter study of its Pure-Vu System in 100 hospitalized patients receiving a diagnostic colonoscopy.

2. The Pure-Vu System cleans the colon intraprocedurally to allow for improved visualization. The study's primary endpoint will be assessed on the Boston Bowel Preparation Scale Index.

3. Motus GI expects the study will be completed in the fourth quarter of 2018.

4. New York City-based NYU Langone Health's Seth Gross, MD, is serving as principal investigator. He said, "Hospitalized patients are generally very difficult to prep for colonoscopy procedures due to serious emergent conditions, such as undiagnosed GI bleeding, and other factors such as ongoing illnesses, comorbidities and new medications. This is a serious challenge, as inadequate bowel preparation is a major impediment to achieving a quality colonoscopy and can lead to long procedure times, the need to repeat procedures, extended hospital stays and delayed diagnoses, all of which significantly increase costs for hospitals and interfere with quality care for patients."

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast